Cargando…

Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults

BACKGROUND: The primary aim of this work was to present the prevalence data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a representative 3-year longitudinal survey (ages 18+ years) that captured information on patterns of self-reported pain interference and pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Scott P, Glasheen, Cristie, Roland, Carl L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935147/
https://www.ncbi.nlm.nih.gov/pubmed/27418863
http://dx.doi.org/10.2147/SAR.S102251
_version_ 1782441418058366976
author Novak, Scott P
Glasheen, Cristie
Roland, Carl L
author_facet Novak, Scott P
Glasheen, Cristie
Roland, Carl L
author_sort Novak, Scott P
collection PubMed
description BACKGROUND: The primary aim of this work was to present the prevalence data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a representative 3-year longitudinal survey (ages 18+ years) that captured information on patterns of self-reported pain interference and prescription pain reliever misuse. A second aim was to assess the degree to which the risk of various types of opioid misuse (onset, desistance, and incidence of dependence) was related to the longitudinal course of self-reported pain interference over the 3-year period. METHODS: We used a two-wave, nationally representative sample of adults (aged 18+ years) in which the baseline data were collected during 2001–2002 and a single follow-up was obtained ~3 years later (2004–2005 with 34,332 respondents with complete data on study variables for both waves). RESULTS: Our findings indicated that ~10% reported high pain interference in the past month at each wave. There was tremendous stability in levels of pain, with ~5% reporting consistent levels of high impairment over the 3-year study, a proxy for chronic pain. Levels of pain were more strongly associated with prescription pain reliever misuse concurrently rather than prospectively, and the association was largely linear, with the likelihood of misuse increasing with levels of pain. Finally, health service factors were also prominent predictors of onset, but not the outcomes, of desistance or transitions to problem use. CONCLUSION: This study is the first to use a nationally representative sample with measures of pain and drug use history collected over an extended period. These results may help provide clinicians with an understanding that the risk of misuse is greatest when pain is active and may help guide the selection of appropriate intervention materials and monitor strategies for those at greatest risk.
format Online
Article
Text
id pubmed-4935147
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49351472016-07-14 Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults Novak, Scott P Glasheen, Cristie Roland, Carl L Subst Abuse Rehabil Original Research BACKGROUND: The primary aim of this work was to present the prevalence data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a representative 3-year longitudinal survey (ages 18+ years) that captured information on patterns of self-reported pain interference and prescription pain reliever misuse. A second aim was to assess the degree to which the risk of various types of opioid misuse (onset, desistance, and incidence of dependence) was related to the longitudinal course of self-reported pain interference over the 3-year period. METHODS: We used a two-wave, nationally representative sample of adults (aged 18+ years) in which the baseline data were collected during 2001–2002 and a single follow-up was obtained ~3 years later (2004–2005 with 34,332 respondents with complete data on study variables for both waves). RESULTS: Our findings indicated that ~10% reported high pain interference in the past month at each wave. There was tremendous stability in levels of pain, with ~5% reporting consistent levels of high impairment over the 3-year study, a proxy for chronic pain. Levels of pain were more strongly associated with prescription pain reliever misuse concurrently rather than prospectively, and the association was largely linear, with the likelihood of misuse increasing with levels of pain. Finally, health service factors were also prominent predictors of onset, but not the outcomes, of desistance or transitions to problem use. CONCLUSION: This study is the first to use a nationally representative sample with measures of pain and drug use history collected over an extended period. These results may help provide clinicians with an understanding that the risk of misuse is greatest when pain is active and may help guide the selection of appropriate intervention materials and monitor strategies for those at greatest risk. Dove Medical Press 2016-06-30 /pmc/articles/PMC4935147/ /pubmed/27418863 http://dx.doi.org/10.2147/SAR.S102251 Text en © 2016 Novak et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Novak, Scott P
Glasheen, Cristie
Roland, Carl L
Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title_full Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title_fullStr Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title_full_unstemmed Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title_short Prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of US adults
title_sort prescription pain reliever misuse and levels of pain impairment: 3-year course in a nationally representative outpatient sample of us adults
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935147/
https://www.ncbi.nlm.nih.gov/pubmed/27418863
http://dx.doi.org/10.2147/SAR.S102251
work_keys_str_mv AT novakscottp prescriptionpainrelievermisuseandlevelsofpainimpairment3yearcourseinanationallyrepresentativeoutpatientsampleofusadults
AT glasheencristie prescriptionpainrelievermisuseandlevelsofpainimpairment3yearcourseinanationallyrepresentativeoutpatientsampleofusadults
AT rolandcarll prescriptionpainrelievermisuseandlevelsofpainimpairment3yearcourseinanationallyrepresentativeoutpatientsampleofusadults